Real-time PCR analysis of the N-acetyltransferase NAT1 allele *3, *4, 0, *11, *14 and *17 polymorphism in squamous cell cancer of head and neck

Carcinogenesis

Volumn 22, Issue 9, 2001, Pages 1405-1412

  Fronhoffs, Stefan ^a   Brüning, Thomas ^b   Ortiz Pallardo, Elena ^a   Bröde, Peter ^c   Koch, Brigitte ^a   Harth, Volker ^b   Sachinidis, Agapios ^a   Bolt, Hermann Maximillian ^b   Herberhold, Claus ^d   Vetter, Hans ^a   Ko, Yon ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

^d UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; AROMATIC AMINE; CARCINOGEN; CIGARETTE SMOKE; ENZYME;

ACETYLATOR PHENOTYPE; ADULT; AGED; ALLELE; ARTICLE; CANCER RESEARCH; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CAUCASIAN; CONTROLLED STUDY; DETOXIFICATION; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HEAD AND NECK CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MODULATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPRODUCIBILITY; SQUAMOUS CELL CARCINOMA; XENOBIOTIC METABOLISM;

EID: 0034812587     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Genetic polymorphism of N-acetyltransferase-2, glutathione S-transferase-M1 and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer
2. Glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes and the risk of smoking-related oral and pharyngeal cancers
3. Glutathione S-transferase M1 and susceptibility to nasopharyngeal carcinoma
4. Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to head-and-neck squamous-cell carcinoma
5. GSTM1, GSTT1, GSTP1, CYP1A1 and NAT1 polymorphisms, tobacco use and the risk of head and neck cancer
6. Tobacco and alcohol consumption in relation to the development of multiple primary cancers
7. Comparative epidemiology of tobacco-related cancers
8. Smoking and drinking in relation to oral and pharyngeal cancer
9. Recent advances in the etiology and epidemiology of head and neck cancer
10. Epidemiology of cancer from exposure to arylamines
11. Black (air-cured) and blond (flue-cured) tobacco cancer risk. IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens
12. Polymorphisms for aromatic amine metabolism in humans: Relevance for human carcinogenesis
13. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases
14. Chapter 20. Polymorphic NATs and cancer predisposition
15. Structural heterogeneity of Caucasian N-acetyltransferase at the NAT1 gene locus
16. Nomenclature for N-acetyltransferases
17. A restriction fragment length polymorphism assay that differentiates human N-acetyltransferase-1 (NAT1) alleles
18. Human acetyltransferase polymorphisms
19. Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe
20. Functional polymorphism of the human arylamine N-acetyltransferase type 1 gene caused by C190T and G560A mutations
21. Variants of N-acetyltransferase NAT1 and a case-control study of colorectal adenomas
22. Characterization of naturally occurring and recombinant human N-acetyltransferase variants encoded by NAT1
23. Identification of a novel allele at the human NAT1 acetyltransferase locus
24. Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: Association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue
25. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer
26. The role of N-acetylation polymorphisms in smoking-associated bladder cancer: Evidence of a gene-gene-exposure three-way interaction
27. Inherited polymorphism in the N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and susceptibility to gastric and colorectal adenocarcinoma
28. N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk
29. Association of the NAT1*10 genotype with increased chromosome aberrations and higher lung cancer risk in cigarette smokers
30. Role of arylamine N-acetyltransferase 1 and 2 (NAT1 and NAT2) genotypes in susceptibility to oral/pharyngeal and laryngeal cancers
31. Association of arylamine N-acetyltransferases NAT1 and NAT2 genotypes to laryngeal cancer risk
32. A pilot study testing the association between N-acetyltransferases 1 and 2 and risk of oral squamous cell carcinoma in Japanese people
33. Monitoring hybridization during polymerase chain reaction
34. The LightCycler: A microvolume multisample fluorimeter with rapid temperature control
35. Continuous fluorescence monitoring of rapid cycle DNA amplification
36. Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility
37. N-acetyltransferase 1 genetic polymorphism, cigarette smoking, well- done meat intake and breast cancer risk
38. Lack of association between the polyadenylation polymorphism in the NAT1 (acetyltransferase 1) gene and colorectal adenomas
39. A prospective study of N-acetyltransferase genotype, red meat intake and risk of colorectal cancer
40. Correlation between genotype and phenotype of the human arylamine N-acetyltransferase type 1 (NAT1)
41. Metabolic activation of aromatic and heterocyclic N-hydroxyarylamines by wild-type and mutant recombinant human NAT1 and NAT2 acetyltransferases
42. N-Acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis
43. N- and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells
44. Metabolic activation and carcinogen-DNA adduct detection in human larynx
45. Aromatic DNA adducts in larynx biopsies and leukocytes
46. Histological localization of acetyltransferases in human tissue
47. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder
48. N-acetyltransferase 1 genetic polymorphism influences the risk of prostate cancer development
49. A pilot study investigating the role of NAT1 and NAT2 polymorphisms in gastric adenocarcinoma
50. Relationship between NAT1 genotype and phenotype in a Japanese population